🔎 Trials Near Me

홈 › 전립선암 › 테네시

테네시의 전립선암 임상 시험

전립선암 관련 연구 47개가 테네시 내 여러 지역에서 참여자를 모집하고 있습니다.

테네시의 도시

공식 연구 텍스트(영어)

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

  • Vanderbilt University/Ingram Cancer Center, Nashville
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT03866382

Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors

  • Sarah Cannon Research Institute - Pharmacy, Nashville
  • SCRI Oncology Partners, Nashville
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 11. 10. 업데이트됨 · NCT04557449

Study of Oral MRT-2359 With Apalutamide in Prostate Cancer

  • Sarah Cannon Research Institute, Nashville
피험자 모집 중2상
18세 이상 · 남성 · 2026. 11. 5. 업데이트됨 · NCT07745361

A Study Evaluating the Safety, Pharmacokinetics, and Preliminary Activity of GDC-1261 in Participants With Advanced or Metastatic Prostate Cancer

  • Sarah Cannon Research Institute, Nashville
피험자 모집 중1/2상
18세 이상 · 남성 · 2026. 11. 5. 업데이트됨 · NCT07567846

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

  • Sarah Cannon Research Institute, Nashville
  • Tennessee Oncology PLLC, Nashville
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT06465069

A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1)

  • Urology Associates, Nashville
피험자 모집 중3상
18세 이상 · 남성 · 2026. 11. 3. 업데이트됨 · NCT07723248

A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer

  • Tennessee Oncology, Nashville
피험자 모집 중1상
18세 이상 · 남성 · 2026. 11. 3. 업데이트됨 · NCT06095089

Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer

  • Sarah Cannon Research Institute, Nashville
  • Urology Associates, Nashville
피험자 모집 중1/2상
18세 이상 · 남성 · 2026. 11. 3. 업데이트됨 · NCT06800313

A Study of JNJ-101556143 in Participants With Metastatic Prostate Cancer

  • The Conrad Pearson Clinic, Germantown
피험자 모집 중2상
18세 이상 · 남성 · 2026. 11. 3. 업데이트됨 · NCT07832292

A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

  • Memphis VA Medical Center ( Site 0072), Memphis
  • SCRI Oncology Partners ( Site 0074), Nashville
  • Henry-Joyce Cancer Clinic ( Site 0042), Nashville
피험자 모집 중3상
18세 이상 · 남성 · 2026. 10. 30. 업데이트됨 · NCT06925737

Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)

  • Sarah Cannon Research, Nashville
피험자 모집 중1상
18세 ~ 100세 · 남성 · 2026. 10. 29. 업데이트됨 · NCT05519449

Study of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors

  • Tennessee Oncology PLLC, Nashville
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 10. 29. 업데이트됨 · NCT07288359

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

  • SCRI Oncology Partners, Nashville
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 10. 26. 업데이트됨 · NCT06172478

A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

  • Research Site 136, Nashville
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 10. 21. 업데이트됨 · NCT05914116

A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

  • The West Clinic, PLLC dba West Cancer Center ( Site 0063), Germantown
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 10. 20. 업데이트됨 · NCT06136650

A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer

  • Sarah Cannon Research Institute Oncology Partners, Nashville
  • United States Oncology Regulatory Affairs Corporate Office, Nashville
피험자 모집 중3상
18세 이상 · 남성 · 2026. 10. 20. 업데이트됨 · NCT07213674

AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)

  • Research Site, Nashville
피험자 모집 중3상
18세 이상 · 남성 · 2026. 10. 19. 업데이트됨 · NCT07611110

Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors

  • Sarah Cannon Research Institute, Nashville
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 10. 15. 업데이트됨 · NCT06239194

Saruparib in Combination With Physician's Choice of ARPI in Patients With mHSPC Previously Treated With Docetaxel or 177Lu-PSMA Therapy Without Disease Progression and PSA ≥ 0.2 ng/mL (EvoPAR-PR05)

  • Research Site, Nashville
피험자 모집 중3상
18세 이상 · 남성 · 2026. 10. 15. 업데이트됨 · NCT07711002

Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC

  • Tennessee Oncology PLLC, Chattanooga
피험자 모집 중3상
18세 ~ 100세 · 남성 · 2026. 10. 15. 업데이트됨 · NCT06855277

A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation

  • Research Site, Nashville
피험자 모집 중3상
18세 이상 · 남성 · 2026. 10. 14. 업데이트됨 · NCT06952803

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

  • Tennessee Oncology, PLLC - Chattanooga Downtown, Chattanooga
  • Tennessee Oncology PLLC, Chattanooga
  • Tennessee Oncology, PLLC - Chattanooga Med Park II, Chattanooga
  • 외 20개
피험자 모집 중3상
18세 이상 · 남성 · 2026. 10. 14. 업데이트됨 · NCT07028853

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

  • Vanderbilt University/Ingram Cancer Center, Nashville
피험자 모집 중3상
18세 이상 · 남성 · 2026. 10. 8. 업데이트됨 · NCT03678025

FOG-001 in Locally Advanced or Metastatic Solid Tumors

  • Sarah Cannon Research Institute, Nashville
  • Vanderbilt Ingram Cancer Center, Nashville
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 10. 7. 업데이트됨 · NCT05919264

A Study of GSK5458514 Administered Alone or In Combination With Other Anti-Cancer Agents in Participants With Prostate Cancer

  • GSK Investigational Site, Nashville
피험자 모집 중1/2상
18세 이상 · 남성 · 2026. 10. 5. 업데이트됨 · NCT06990880

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

  • Sarah Cannon Research Institute, Nashville
피험자 모집 중1/2상
12세 이상 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT04585750

DESTINY-PANTUMOUR04

  • Research Site, Nashville
피험자 모집 중관찰 연구
18세 ~ 130세 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT07124000

A Study in Patients With Metastatic Castration-Resistant Prostate Cancer

  • Tennessee Oncology, Nashville
피험자 모집 중1상
18세 이상 · 남성 · 2026. 9. 24. 업데이트됨 · NCT07719361

High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers

  • Memphis VA Medical Center, Memphis, TN, Memphis
  • Tennessee Valley Healthcare System Nashville Campus, Nashville, TN, Nashville
피험자 모집 중2상
18세 이상 · 남성 · 2026. 9. 17. 업데이트됨 · NCT05011383

Phase 1 Trial to Study JANX013 and JANX007 Combination in mCRPC

  • Sarah Cannon Research Institute, Nashville
피험자 모집 중1상
18세 이상 · 남성 · 2026. 9. 17. 업데이트됨 · NCT07813637

Trial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate Cancer

  • Sarah Cannon Research Institute Oncology Partners, Nashville
피험자 모집 중1상
18세 이상 · 남성 · 2026. 9. 15. 업데이트됨 · NCT07493512

Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy

  • Urology Associates of Nashville, Nashville
피험자 모집 중3상
18세 이상 · 남성 · 2026. 9. 11. 업데이트됨 · NCT06056830

A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors

  • Sarah Cannon Research Center, Nashville
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 9. 업데이트됨 · NCT06440005

A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer

  • Tennessee Oncology Nashville, Nashville
피험자 모집 중2상
18세 이상 · 남성 · 2026. 9. 3. 업데이트됨 · NCT07005154

Study of JANX014 in Subjects With Metastatic Castration-Resistant Prostate Cancer

  • SCRI Oncology Partners, Nashville
피험자 모집 중1상
18세 이상 · 남성 · 2026. 9. 3. 업데이트됨 · NCT07545811

A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

  • Henry-Joyce Cancer Clinic, Nashville
피험자 모집 중2상
18세 이상 · 남성 · 2026. 8. 17. 업데이트됨 · NCT06842498

Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors

  • Investigative Site #102, Nashville
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 7. 23. 업데이트됨 · NCT06545942

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

  • Vanderbilt University/Ingram Cancer Center, Nashville
피험자 모집 중3상
18세 이상 · 남성 · 2026. 7. 14. 업데이트됨 · NCT06592924

International Registry for Men With Advanced Prostate Cancer (IRONMAN)

  • Memphis VA Medical Center, Memphis
  • Baptist Clinical Research Institute, Memphis
피험자 모집 중관찰 연구
21세 이상 · 남성 · 2026. 5. 22. 업데이트됨 · NCT03151629

A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

  • Sarah Cannon Research Institute (SCRI) Oncology Partners, Nashville
  • Vanderbilt University Medical Center, Nashville
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 2. 13. 업데이트됨 · NCT06778863

ClinicalTrials.gov 출처, 2026. 11. 15. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.